Lupin Secures CDSCO Panel Clearance for Phase III COPD Inhaler Trial
- 19 September 2025
- 1 month ago
Lupin Secures CDSCO Panel Nod for Phase IV Trial of Budesonide-Based COPD Inhaler
- 19 September 2025
- 1 month ago
Lupin bags USFDA approval for Multiple myeloma treatment
- 17 September 2025
- 1 month ago
Lupin gets 6 USFDA observations for Nagpur facility
- 17 September 2025
- 1 month ago
Lupin Manufacturing Solutions: Empagliflozin API gets CADIFA approval from ANVISA, Brazil
- 15 September 2025
- 1 month ago
Lupin Type 2 Diabetes Drug Canagliflozin Bags USFDA Tentative Approval
- 28 July 2025
- 3 months ago
Recent News
GLP-1 Receptor Agonists Linked to Lower Risk of Ea...
- 03 November, 2025
Ketogenic diet may protect against stress experien...
- 03 November, 2025
STORM-PE Trial: Mechanical Thrombectomy Shows Supe...
- 03 November, 2025
AIIMS INI CET January 2026 admit cards released
- 03 November, 2025
3 pharma students drown in Payyambalam beach in Ke...
- 03 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.






